Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Molecular Medicine
Link
http://www.nature.com/articles/gt200999.pdf
Reference45 articles.
1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987–996.
2. Barnholtz-Sloan JS, Sloan AE, Schwartz AG . Relative survival rates and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973–1997. J Neurosurg 2003; 99: 458–466.
3. Tait MJ, Petrik V, Loosemore A, Bell BA, Papadopoulos MC . Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases. Br J Neurosurg 2007; 21: 496–500.
4. Hou LC, Veeravagu A, Hsu AR, Tse VC . Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg Focus 2006; 20: E3.
5. Wood KW, Cornwell WD, Jackson JR . Past and future of the mitotic spindle as an oncology target. Curr Opin Pharmacol 2001; 1: 370–377.
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MicroRNAs as prognostic markers and therapeutic targets in gliomas;Non-coding RNA Research;2022-09
2. Brain Cancer Treatment; A Systematic Review;International Journal of Cancer Management;2022-07-30
3. Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier;Frontiers in Medical Technology;2021-08-10
4. Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems;Life Sciences;2021-06
5. Hemagglutinating virus of Japan‐envelope containing programmed cell death‐ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma;Cancer Science;2020-11-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3